Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Injuries | 10 | 2022 | 924 | 1.560 |
Why?
|
| Spinal Fusion | 8 | 2021 | 1283 | 1.050 |
Why?
|
| Decompression, Surgical | 3 | 2020 | 608 | 0.960 |
Why?
|
| Lumbosacral Region | 6 | 2021 | 291 | 0.900 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 2070 | 0.830 |
Why?
|
| Streptococcus anginosus | 1 | 2022 | 24 | 0.810 |
Why?
|
| Finite Element Analysis | 2 | 2020 | 432 | 0.740 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2021 | 58 | 0.720 |
Why?
|
| Spinal Stenosis | 2 | 2021 | 263 | 0.720 |
Why?
|
| Lumbar Vertebrae | 8 | 2021 | 1872 | 0.680 |
Why?
|
| Nerve Regeneration | 4 | 2018 | 795 | 0.660 |
Why?
|
| Spinal Cord Diseases | 1 | 2022 | 293 | 0.640 |
Why?
|
| Nasal Cavity | 1 | 2021 | 304 | 0.630 |
Why?
|
| Nose Neoplasms | 1 | 2021 | 249 | 0.630 |
Why?
|
| Skull Base Neoplasms | 1 | 2021 | 270 | 0.570 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2021 | 549 | 0.550 |
Why?
|
| Internal Fixators | 4 | 2021 | 183 | 0.540 |
Why?
|
| Spinal Neoplasms | 3 | 2020 | 715 | 0.510 |
Why?
|
| Osteosarcoma | 1 | 2021 | 896 | 0.490 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1263 | 0.350 |
Why?
|
| Axons | 4 | 2018 | 1673 | 0.310 |
Why?
|
| Contusions | 2 | 2020 | 79 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 36362 | 0.290 |
Why?
|
| Hot Temperature | 1 | 2013 | 1440 | 0.280 |
Why?
|
| Central Nervous System | 1 | 2014 | 1337 | 0.270 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 1007 | 0.270 |
Why?
|
| Neurons | 4 | 2018 | 9443 | 0.260 |
Why?
|
| DNA Helicases | 2 | 2001 | 851 | 0.260 |
Why?
|
| Computer Simulation | 1 | 2019 | 6230 | 0.250 |
Why?
|
| Pain Measurement | 3 | 2021 | 3546 | 0.250 |
Why?
|
| Cockayne Syndrome | 2 | 2001 | 20 | 0.240 |
Why?
|
| Spine | 3 | 2020 | 1118 | 0.230 |
Why?
|
| Neurology | 1 | 2012 | 778 | 0.230 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1598 | 0.230 |
Why?
|
| Cervical Vertebrae | 3 | 2019 | 981 | 0.220 |
Why?
|
| Brain | 3 | 2014 | 27060 | 0.200 |
Why?
|
| RNA Polymerase II | 2 | 2002 | 539 | 0.190 |
Why?
|
| Diskectomy, Percutaneous | 1 | 2020 | 14 | 0.180 |
Why?
|
| Stem Cells | 1 | 2013 | 3522 | 0.170 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2019 | 18 | 0.170 |
Why?
|
| Postoperative Complications | 6 | 2020 | 15627 | 0.170 |
Why?
|
| Pain | 2 | 2021 | 5075 | 0.170 |
Why?
|
| Spinal Fractures | 2 | 2021 | 705 | 0.170 |
Why?
|
| Caspases | 1 | 2002 | 876 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 461 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 2568 | 0.160 |
Why?
|
| Models, Anatomic | 2 | 2020 | 682 | 0.160 |
Why?
|
| Spondylolisthesis | 1 | 2020 | 175 | 0.160 |
Why?
|
| Locomotion | 3 | 2022 | 388 | 0.160 |
Why?
|
| Abscess | 1 | 2022 | 606 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2021 | 300 | 0.150 |
Why?
|
| Surgical Mesh | 1 | 2021 | 310 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2013 | 6603 | 0.150 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 344 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 696 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2022 | 597 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2014 | 1114 | 0.130 |
Why?
|
| Spinal Diseases | 1 | 2021 | 564 | 0.130 |
Why?
|
| Oncolytic Virotherapy | 1 | 2022 | 516 | 0.130 |
Why?
|
| Symporters | 1 | 2018 | 361 | 0.130 |
Why?
|
| DNA Repair | 2 | 2001 | 2044 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2022 | 888 | 0.120 |
Why?
|
| Osteomyelitis | 1 | 2018 | 407 | 0.120 |
Why?
|
| Humans | 33 | 2022 | 760437 | 0.110 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 149 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 1154 | 0.110 |
Why?
|
| Range of Motion, Articular | 1 | 2020 | 1585 | 0.110 |
Why?
|
| Printing | 1 | 2013 | 46 | 0.110 |
Why?
|
| Spinal Cord | 5 | 2022 | 1817 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 1409 | 0.110 |
Why?
|
| Janus Kinases | 1 | 2014 | 249 | 0.110 |
Why?
|
| DNA Damage | 1 | 2002 | 2441 | 0.100 |
Why?
|
| Ultraviolet Rays | 3 | 2002 | 1079 | 0.100 |
Why?
|
| Stereotaxic Techniques | 1 | 2014 | 554 | 0.100 |
Why?
|
| Bone Screws | 1 | 2015 | 532 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2242 | 0.100 |
Why?
|
| Pain Threshold | 1 | 2015 | 603 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2014 | 23397 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2016 | 1877 | 0.090 |
Why?
|
| Animals | 13 | 2022 | 168253 | 0.090 |
Why?
|
| Immunoblotting | 3 | 2002 | 1647 | 0.090 |
Why?
|
| DNA Repair Enzymes | 2 | 2001 | 346 | 0.080 |
Why?
|
| Apoptosis | 2 | 2002 | 9468 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 1626 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2022 | 5966 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2501 | 0.080 |
Why?
|
| Time | 2 | 2020 | 544 | 0.080 |
Why?
|
| Delirium | 1 | 2020 | 1667 | 0.080 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 252 | 0.080 |
Why?
|
| Male | 16 | 2021 | 360035 | 0.070 |
Why?
|
| Thoracic Vertebrae | 2 | 2010 | 595 | 0.070 |
Why?
|
| Age Factors | 4 | 2019 | 18379 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1674 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2022 | 3481 | 0.070 |
Why?
|
| Longevity | 1 | 2014 | 1062 | 0.070 |
Why?
|
| Neurosurgery | 1 | 2013 | 679 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64591 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15257 | 0.070 |
Why?
|
| Proteins | 1 | 2001 | 6033 | 0.070 |
Why?
|
| Cisplatin | 2 | 2002 | 1647 | 0.060 |
Why?
|
| Reoperation | 1 | 2016 | 4300 | 0.060 |
Why?
|
| Rats | 3 | 2022 | 23712 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1418 | 0.060 |
Why?
|
| Quality Improvement | 2 | 2020 | 3798 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2001 | 4879 | 0.060 |
Why?
|
| Female | 14 | 2021 | 391875 | 0.060 |
Why?
|
| Cell Division | 2 | 2001 | 4461 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8522 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2001 | 4106 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 185 | 0.050 |
Why?
|
| Microglia | 2 | 2022 | 1357 | 0.050 |
Why?
|
| DNA Adducts | 1 | 2002 | 94 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2016 | 3249 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 189 | 0.050 |
Why?
|
| Thionucleotides | 1 | 2001 | 112 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2002 | 218 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 20551 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4474 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 815 | 0.050 |
Why?
|
| Middle Aged | 9 | 2021 | 220382 | 0.050 |
Why?
|
| Adult | 8 | 2021 | 220781 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18216 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 261 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2014 | 3436 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2022 | 11526 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 739 | 0.050 |
Why?
|
| Transformation, Genetic | 1 | 2001 | 192 | 0.050 |
Why?
|
| Aged | 9 | 2021 | 168840 | 0.050 |
Why?
|
| Prostheses and Implants | 2 | 2021 | 1272 | 0.040 |
Why?
|
| Sex Factors | 1 | 2014 | 10538 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 58859 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2022 | 2975 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2001 | 407 | 0.040 |
Why?
|
| Longitudinal Ligaments | 1 | 2019 | 25 | 0.040 |
Why?
|
| Palliative Care | 1 | 2015 | 3585 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 3159 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 609 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 751 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 580 | 0.040 |
Why?
|
| Geographic Information Systems | 1 | 2021 | 281 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2016 | 2322 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 1693 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2001 | 308 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 548 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2021 | 80430 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2014 | 7948 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2001 | 712 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 511 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4241 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 3792 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 249 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 665 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2001 | 1755 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2021 | 408 | 0.040 |
Why?
|
| Iran | 1 | 2020 | 738 | 0.040 |
Why?
|
| DNA Primers | 1 | 2001 | 2820 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18955 | 0.030 |
Why?
|
| Back Pain | 1 | 2021 | 545 | 0.030 |
Why?
|
| Research Design | 1 | 2012 | 6168 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2001 | 12785 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2002 | 3097 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2001 | 1597 | 0.030 |
Why?
|
| ras Proteins | 1 | 2001 | 1052 | 0.030 |
Why?
|
| Mice | 5 | 2022 | 81402 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 761 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2001 | 3603 | 0.030 |
Why?
|
| Gliosis | 1 | 2016 | 244 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2015 | 188 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2019 | 1807 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2002 | 2610 | 0.030 |
Why?
|
| Transfection | 1 | 2002 | 5776 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4567 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 246 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6128 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 509 | 0.030 |
Why?
|
| Binding Sites | 1 | 2002 | 6042 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 13338 | 0.030 |
Why?
|
| Interneurons | 1 | 2018 | 593 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 9003 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2016 | 464 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 20078 | 0.030 |
Why?
|
| Neoplasms | 1 | 2001 | 22083 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2016 | 653 | 0.020 |
Why?
|
| Lymphoma | 1 | 2001 | 1901 | 0.020 |
Why?
|
| Cell Line | 2 | 2002 | 15598 | 0.020 |
Why?
|
| Atrophy | 1 | 2016 | 1631 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 54339 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 3685 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 2911 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2022 | 3904 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1849 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5865 | 0.020 |
Why?
|
| Protein Binding | 1 | 2002 | 9340 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 1434 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1736 | 0.020 |
Why?
|
| Time Factors | 3 | 2016 | 39947 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2111 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2010 | 248 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7582 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3874 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 892 | 0.020 |
Why?
|
| Astrocytes | 1 | 2016 | 1345 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2013 | 908 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 11096 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6413 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 2010 | 511 | 0.020 |
Why?
|
| Health Status | 1 | 2019 | 4071 | 0.020 |
Why?
|
| Genotype | 1 | 2001 | 12976 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2001 | 14397 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5764 | 0.020 |
Why?
|
| Bone Development | 1 | 2007 | 472 | 0.010 |
Why?
|
| Risk Factors | 2 | 2020 | 74055 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2013 | 1870 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2001 | 16 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21322 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 2058 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 59068 | 0.010 |
Why?
|
| Synapses | 1 | 2010 | 1762 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11900 | 0.010 |
Why?
|
| United States | 2 | 2020 | 72202 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8216 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2870 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22121 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23953 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 17854 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13616 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 687 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41366 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9533 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 30025 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 1314 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 2911 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 8689 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3710 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8311 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7597 | 0.000 |
Why?
|
| Infant | 1 | 2007 | 36183 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2007 | 42209 | 0.000 |
Why?
|
| Child | 1 | 2007 | 80086 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 88196 | 0.000 |
Why?
|
Concepts
(242)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_